Ciarán Newell

Ciarán Newell

Auto-generated profile, based on publicly available information

Ciarán Newell

Dorset HealthCare University NHS Foundation Trust, Poole, UK

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2017 in JMIR Research Protocols
Verified
Journal Article
Open access
SMSarah Muir
Sarah Muir
CNCiarán Newell
Ciarán Newell
JGJess Griffiths
Jess Griffiths
KWKathy Walker
Kathy Walker
HHHolly Hooper
Holly Hooper
KAKatherine Marie Appleton
Katherine Marie Appleton
In the UK, eating disorders affect upward of 725,000 people per year, and early assessment and treatment are important for patient outcomes. Around a third of adult outpatients in the UK who are referred to specialist eating disorder services do not attend, which could be related to patient factors related to ambivalence, fear, and a lack of confidence about change. This lack of engagement has a negative impact on the quality of life of patients and has implications for service costs. To describe the development of a Web-based program ("MotivATE") designed for delivery at the point of referral to an eating disorder service, with the aim of increasing service attendance. We used intervention mapping and a person-based approach to design the MotivATE program and conducted a needs assessment to determine the current impact of service nonattendance on patients (via a review of the qualitative evidence) and services (through a service provision survey to understand current issues in UK services). Following the needs assessment, we followed the five steps of program development outlined by Bartholomew et al (1998): (1) creating a matrix of proximal program objectives; (2) selecting theory-based intervention methods and strategies; (3) designing and organizing the program; (4) specifying adoption and implementation plans; and (5) generating program evaluation plans. The needs assessment identified current nonattendance rates of 10%-32%. We defined the objective of MotivATE as increasing attendance rates at an eating disorder service and considered four key determinants of poor attendance: patient ambivalence about change, low patient self-efficacy, recognition of the need to change, and expectations about assessment. We chose aspects of motivational interviewing, self-determination theory, and the use of patient stories as the most appropriate ways to enable change. Think-aloud piloting with people with lived experience of an eating disorder resulted in positive feedback on the MotivATE program. Participants related well to the stories used. Nonetheless, because of feedback, we further modified the program in line with patients' stage of change and addressed issues with the language used. A consultation with service staff meant that we could make clear implementation plans. Finally, a randomized controlled trial is currently underway to evaluate the MotivATE program. Using intervention mapping, we have developed a novel pretreatment Web-based program that is acceptable to people with eating disorders. To our knowledge, this is the first such program. The model of development described here could be a useful template for designing further programs for other difficult-to-engage populations.

27 February 2019 in Journal of Medical Internet Research
Verified
Journal Article
Open access
JDJames Denison-Day
James Denison-Day
SMSarah Muir
Sarah Muir
CNCiarán Newell
Ciarán Newell
KAKatherine Marie Appleton
Katherine Marie Appleton
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Early assessment and treatment of eating disorder patients is important for patient outcome. However up to a third of people referred for treatment do not access services and 16.4% do not attend their first scheduled assessment appointment. MotivATE is a fully automated novel web-based program intended to increase motivation to change eating disorder behaviours, designed for delivery at the point of invitation to an eating disorder service, with the aim of increasing service attendance. Objective: This paper assesses the impact of MotivATE on attendance at assessment when compared with treatment as usual. Methods: A zelen randomised control design was used. All individuals referred to a specialist eating disorder service, Kimmeridge House, Dorset, UK, over the course of a year (24/10/17 - 23/10/18), were randomised to treatment as usual (TAU) or treatment as usual plus an additional letter offering access to MotivATE. Attendance at the initial scheduled assessment appointment was assessed. Logistic regression analysis assessed the impact of MotivATE on attendance at assessment. Additional analyses based on levels of engagement with MotivATE were also undertaken. Results: A total of 313 participants took part (156 randomised to TAU, 157 randomised to receive the additional offer to access MotivATE). Intention-to-treat analysis between conditions showed no impact of MotivATE on attendance at assessment (OR = 1.35, 95% CI = 0.69-2.66, p = 0.38). Examination of the usage data indicated that only 53 of 157 participants (33%) in the MotivATE condition registered with the web-based intervention. An analysis comparing those that registered with the intervention with those that did not found greater attendance at assessment in those that had registered (OR = 9.46, 95% CI = 1.22-73.38, p = .03). Conclusions: Our primary analyses suggest no impact of MotivATE on attendance at the first scheduled assessment appointment, but secondary analyses revealed limited engagement with the program, and improved attendance in those who did engage. It is unclear, however, if engagement with the program increased motivation and so attendance, or if more motivated individuals were more likely to access the intervention. Further research is required to facilitate engagement with web-based interventions, and to understand the full value of MotivATE for users. Clinical Trial: ClinicalTrails.gov. Trial number: NCT02777944 (19/05/2016)

1 February 2025 in Health Technology Assessment
Verified
Journal Article
Open access
BİBaşak İnce
Başak İnce
MPMatthew D Phillips
Matthew D Phillips
BDBethan Dalton
Bethan Dalton
MIMadeleine Irish
Madeleine Irish
HWHannah Webb
Hannah Webb
USUlrike Schmidt
Ulrike Schmidt
Background: A substantial proportion of anorexia nervosa patients require intensive treatments, commonly inpatient or day-patient treatment. The relative merits of these treatments for adults with anorexia nervosa are unknown. Therefore, a trial investigating the clinical effectiveness and cost-effectiveness of inpatient treatment-as-usual versus a stepped-care day-patient approach in adults with anorexia nervosa (DAISIES) was commissioned. This trial terminated prematurely due to poor recruitment, mainly resulting from COVID-19’s impact on service provision. Objective: We describe the rationale, methods and available outcomes of the DAISIES trial. Reasons behind the trial’s failure and implications for future research are investigated. Design: A two-arm multicentre open-label parallel-group non-inferiority randomised controlled trial, evaluating the effectiveness, acceptability and cost-effectiveness of two intensive treatments for adults with severe anorexia nervosa. Setting: Specialist eating-disorder services in the United Kingdom with inpatient and/or day-patient treatment facilities. Participants: Adults (age 17 +) with severe anorexia nervosa (body mass index ≤ 16 kg/m2) requiring intensive treatment and (optionally) their carers. Intended sample size: 386. Interventions: Inpatient treatment-as-usual and a stepped-care day-patient treatment approach (with the option of initial inpatient treatment for medical stabilisation). Main outcome measures: The primary outcome was body mass index at 12 months post randomisation. Qualitative interviews conducted during the trial included semistructured interviews to investigate patients’, families’ and clinicians’ views on treatments. Results: During the 16-month recruitment period (November 2020 to March 2022), 53 patients were approached. Of these, 15 were enrolled and randomly allocated to the inpatient treatment-as-usual (n = 7) or day-patient treatment (n = 8) treatment arms. All participants were female with a mean (standard deviation) age of 24.8 (9.1) years and a mean (standard deviation) body mass index of 14.4 (1.6) kg/m2. Patients’ body mass indexes had increased similarly in both groups at 12 months. Participants perceived the stepped-care day-patient treatment approach to be more acceptable than inpatient treatment-as-usual. Qualitative interviews with patients, carers and clinicians suggested valued (e.g. multidisciplinary provision of care) and disliked (e.g. perceived over-focus on weight gain) aspects of treatment. Investigation of the reasons behind the trial’s failure revealed strong treatment preferences among patients as the most common reason for non-participation, alongside the impact of COVID-19 on service provision. Limitations: The main trial questions could not be answered due to low participant numbers. Conclusions: No conclusions can be drawn concerning the clinical and cost-effectiveness of inpatient treatment-as-usual or stepped-care day-patient treatment. The day-patient treatment approach was perceived more positively by patients and carers. Service-related (e.g. reduced clinician time for research), patient-related (e.g. treatment preferences) and wider systemic factors (e.g. reduced service capacity and patient throughput nationally during COVID-19) seem to have contributed to the failure of the DAISIES trial. Future work: Despite the trial’s failure, the need to investigate the effectiveness and experience of intensive treatments of adult anorexia nervosa remains. Alternative trial designs incorporating patient preferences and investigating community-based intensive treatment options have potential to improve acceptability and recruitment. Funding: This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number HTA 17/123/03.

1 February 2025 in Health Technology Assessment
Verified
Journal Article
Open access
BİBaşak İnce
Başak İnce
MPMatthew D Phillips
Matthew D Phillips
BDBethan Dalton
Bethan Dalton
MIMadeleine Irish
Madeleine Irish
HWHannah Webb
Hannah Webb
USUlrike Schmidt
Ulrike Schmidt
This article consists of a citation of a published article describing research funded by the Health Technology Assessment programme under project number 17/123/03, and is provided as as part of the complete record of research outputs for this project. The original publication is available at: https://doi.org/10.1186/s40337-021-00528-z Background: Admissions to intensive treatment (i.e., inpatient [IP] and/or day patient [DP]) for individuals with severe anorexia nervosa (AN) are common. Growing literature indicates potential risks and benefits of each intensive treatment approach; however, existing research has focused on patient and carer perspectives of these treatments. Also, there is scant empirical evidence available for guiding the parameters of intensive treatments for AN. We therefore explored clinicians’ perspectives and experience of supporting adults with severe AN in intensive settings. Methods: We conducted twenty one semi-structured interviews with clinicians who deliver intensive treatments (i.e., IP and/or DP) for individuals with severe AN across four specialist Eating Disorder Services in the United Kingdom between May 2020 and June 2021. We asked clinicians about their views and experiences of supporting individuals with severe AN in intensive treatment settings and the challenges and opportunities associated with IP and DP treatment. Data were analysed using reflexive thematic analysis supported by NVivo software. Results: Five broad and interrelated themes were identified: (1) Intensive Support; (2) The Severity of Patients’ Illnesses; (3) Hope and Recovery; (4) Which Treatment When; (5) Limited Resources; and (6) Carer Burden. We identified various similarities between the two intensive treatment approaches, including the value of intensive and multidisciplinary support and carer involvement, and the challenge of managing complex and unique needs in resource-limited intensive settings. We also found differences in the relationship of treatment to patients’ home environments, the necessity of patient motivation, and the management of risk. Conclusions: Both intensive treatment settings are valued by clinicians; however, there are unique challenges and opportunities for supporting individuals with severe AN within each. Our findings suggest DP treatment may be used as an alternative to IP treatment for individuals with severe AN. However, clear questions remain over which intensive treatment setting is best suited to which patient when and should be the focus of future research. Funding: This publication was funded by the Health Technology Assessment programme as a part of award number 17/123/03. This article reports on one component of the research award A Randomized Controlled Multi-Centre Open-Label Parallel Group Non-Inferiority Trial of the Clinical Effectiveness, Acceptability and Cost-Effectiveness of a “Stepping into Day Treatment Approach” versus Inpatient Treatment as Usual for Anorexia Nervosa in Adult Specialist Eating Disorder Services. For more information about this research please view the award page [https://fundingawards.nihr.ac.uk/award/17/123/03] DOI: https://doi.org/10.1186/s40337-021-00528-z

1 February 2025 in Health Technology Assessment
Verified
Journal Article
Open access
PDF file
BİBaşak İnce
Başak İnce
MPMatthew D Phillips
Matthew D Phillips
BDBethan Dalton
Bethan Dalton
MIMadeleine Irish
Madeleine Irish
HWHannah Webb
Hannah Webb
LSLandau S
Landau S
This article consists of a citation of a published article describing research funded by the Health Technology Assessment programme under project number 17/123/03, and is provided as as part of the complete record of research outputs for this project. The original publication is available at: https://doi.org/10.1002/erv.2975 Objective: The DAISIES trial, comparing inpatient and stepped-care day patient treatment for adults with severe anorexia nervosa was prematurely terminated in March 2022 due to poor recruitment. This qualitative study seeks to understand the difficulties faced during the trial by investigating stakeholders’ views on and experiences of its implementation. Method: Semi-structured interview and focus group transcripts, and trial management and oversight group meeting minutes from May 2020-June 2022 were analysed using thematic analysis. Participants were 47 clinicians and co-investigators involved with the DAISIES trial. The Non-Adoption, Abandonment, Scale-up, Spread, and Sustainability (NASSS) framework was applied to the interpretive themes to classify barriers and facilitators to implementation. Results: Five themes were identified: incompatible participation interests; changing standard practice; concerns around clinical management; systemic capacity and capability issues; and Covid-19 disrupting implementation. Applying the NASSS framework indicated the greatest implementation challenges to arise with the adopters (e.g. patients, clinicians), the organisational systems (e.g. service capacity), and the wider socio-political context (e.g. Covid-19 closing services). Conclusions: Our findings emphasise the top-down impact of systemic-level research implementation challenges. The impact of the Covid-19 pandemic accentuated pre-existing organisational barriers to trial implementation within intensive eating disorder services, further limiting the capacity for research. Funding: This publication was funded by the Health Technology Assessment programme as a part of award number 17/123/03. This article reports on one component of the research award A Randomised Controlled Multi-Centre Open-Label Parallel Group Non-Inferiority Trial of the Clinical Effectiveness, Acceptability and Cost-Effectiveness of a ‘Stepping into Day Treatment’ Approach versus Inpatient Treatment as Usual for Anorexia Nervosa in Adult Specialist Eating Disorder Services. For more information about this research please view the award page [https://fundingawards.nihr.ac.uk/award/17/123/03] DOI: https://doi.org/10.1002/erv.2975

1 February 2025 in Health Technology Assessment
Verified
Journal Article
Open access
BİBaşak İnce
Başak İnce
MPMatthew D Phillips
Matthew D Phillips
BDBethan Dalton
Bethan Dalton
MIMadeleine Irish
Madeleine Irish
HWHannah Webb
Hannah Webb
USUlrike Schmidt
Ulrike Schmidt
This article consists of a citation of a published article describing research funded by the Health Technology Assessment programme under project number 17/123/03, and is provided as as part of the complete record of research outputs for this project. The original publication is available at: https://doi.org/10.1186/s40337-022-00555-4 Background: The COVID-19 pandemic has significantly affected intensive treatment settings (i.e., inpatient [IP] and day patient [DP]) in specialist eating disorder services. However, the impact on clinicians working in these services is largely unknown. We therefore explored the perspectives of those supporting individuals with severe anorexia nervosa (AN) in intensive treatment settings during the pandemic. Methods: Between May 2020 and June 2021, we interviewed clinicians (n = 21) who delivered IP and/or DP treatment to patients with severe AN in four specialist eating disorder services in the United Kingdom. Data relating to experiences during COVID-19 were analysed using reflexive thematic analysis. Results: We identified six themes: Disruptions to Routine Treatment; Introduction of Virtual Treatment; Separation from Treatment, Others and the World; Impact on Recovery; Impact on Staff; and Pressure on Referral Pathways. COVID-19 posed significant challenges to IP and DP services: forcing closures, operating with restrictions and virtual treatment, and impacting delivery of essential treatment components, referral pathways, clinician wellbeing, risk management, and patient isolation and recovery trajectories. Opportunities arose, in particular in DP services offering virtual support. Conclusions: COVID-19 challenged the continuation of multidisciplinary treatment. The findings underline the necessity for medical, psychological, practical, and nutritional support, as well as carer involvement and fostering social connections to remain at the forefront of intensive treatment for severe AN. They also emphasise the uncertainty surrounding which intensive treatment may be best suited to which patient when, particularly within the context of virtual DP support. Funding: This publication was funded by the Health Technology Assessment programme as a part of award number 17/123/03. This article reports on one component of the research award A Randomized Controlled Multi-Centre Open-Label Parallel Group Non-Inferiority Trial of the Clinical Effectiveness, Acceptability and Cost-Effectiveness of a “Stepping into Day Treatment Approach” versus Inpatient Treatment as Usual for Anorexia Nervosa in Adult Specialist Eating Disorder Services. For more information about this research please view the award page [https://fundingawards.nihr.ac.uk/award/17/123/03] DOI: https://doi.org/10.1186/s40337-022-00555-4